Loading…
●Research use only — not for human or veterinary use
Also known as Growth hormone releasing peptide-6
A growth-hormone-releasing hexapeptide acting at the secretagogue receptor, studied in somatotropic-axis signaling research. Supplied as a documented reference standard.
GHRP-6 is a growth-hormone-releasing hexapeptide that acts at the growth-hormone-secretagogue (ghrelin) receptor. In research models it is studied as a secretagogue-class reference within the somatotropic axis.
It is a six-residue peptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂, ~873.0 g/mol) containing D-amino acids that confer stability — a common motif in secretagogue peptides.
See the GHRH and GH signaling overview. GHRP-6 acts through the secretagogue receptor and is studied alongside the selective secretagogue ipamorelin and GHRH analogues such as CJC-1295.
Supplied lyophilised; follow the standard storage and freeze-thaw handling for reconstituted material.
Each lot is documented by HPLC purity and mass-spec identity.
References describe in-vitro and pre-clinical research only. Supplied as a research-use-only reference standard, not for human or veterinary use.
Store lyophilised at -20 °C; reconstituted material at 2–8 °C within the analytical window.
Reconstituted purity tracked by HPLC over the storage window.
Research use only — All products and content are intended strictly for in-vitro laboratory research and analytical use. Not for human or veterinary use, not for consumption, and not for any diagnostic or therapeutic purpose.